Eila Arich-Landkof is the Founder and CEO of Oriel Research Therapeutics (ORT) www.orielresearch.com. Prior to ORT, Eila worked for The Broad Institute of Harvard and MIT, Massachusetts General Hospital, The Whitehead Institute for Biomedical Research, and for leading high tech companies to include Microsoft, Inc, and Cisco Systems. Eila incorporates her unique professional background into data-driven precision medicine. ORT’s first goal is to allow blood tests to detect medical conditions, specifically: Leukemia, Sepsis.
ORT was granted for Google Cloud Startup Platform support and was selected to the Johnson and Johnson innovation labs (JLAB) in Boston, MA